Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (the 'Company'), hereby convenes an extraordinary general meeting in the Company to be held on Monday 17 February 2020 at 12:00 p.m. CET at the offices of Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen, Denmark.

Shareholders who have accepted the voluntary recommended public offer shall disregard this convening notice as such shareholders have no rights to attend and vote at the Extraordinary General Meeting as their shares are sold.


Election of new members of the board of directors of Veloxis Pharmaceuticals A/S (current members are expected to resign)


Craig A. Collard

Tel: +1 919 591 3090

Email: cac@veloxis.com

(C) 2020 Electronic News Publishing, source ENP Newswire